A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS

Targeted protein degradation is an attractive therapeutic strategy to deplete oncogenic proteins in tumours. Here the authors demonstrate the specific targeting of endogenous KRAS protein for degradation from cancer cells, and regression of tumours expressing mutant KRAS in a mouse model.

Guardado en:
Detalles Bibliográficos
Autores principales: Nicolas Bery, Ami Miller, Terry Rabbitts
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/960ac50f46934b108f258aa4907c22dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!